Arachidonic acid induces ER stress and apoptosis in HT-29 human colon cancer cells

References

• Bordoni A, Di Nunzio M, Danesi F, Biagi PL. 2006. Polyunsaturated fatty acids: from diet to binding to ppars and other nuclear receptors. Genes Nutr. 1(2):95–106. doi: 10.1007/BF02829951
   PubMed Web of Science ®Google Scholar
• Brown JR, DuBois RN. 2005. COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol. 23(12):2840–2855. doi: 10.1200/JCO.2005.09.051
   PubMed Web of Science ®Google Scholar
• Calder PC. 2017. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 45(5):1105–1115. doi: 10.1042/BST20160474
   PubMed Web of Science ®Google Scholar
• Calfon M, Zeng H, Urano F, Till JH, Hubbard SR, Harding HP, Clark SG, Ron D. 2002. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature. 415(6867):92–96. doi: 10.1038/415092a
   PubMed Web of Science ®Google Scholar
• Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS. 2005. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-ß-catenin signaling axis. Science. 310(5753):1504–1510. doi: 10.1126/science.1116221
   PubMed Web of Science ®Google Scholar
• Chan AT, Ogino S, Fuchs CS. 2007. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med. 356(21):2131–2142. doi: 10.1056/NEJMoa067208
   PubMed Web of Science ®Google Scholar
• Chan AT, Ogino S, Fuchs CS. 2009. Aspirin use and survival after diagnosis of colorectal cancer. JAMA. 302(6):649–658. doi: 10.1001/jama.2009.1112
   PubMed Web of Science ®Google Scholar
• Chen Y, Brandizzi F. 2013. IRE1: ER stress sensor and cell fate executor. Trends Cell Biol. 23(11):547–555. doi: 10.1016/j.tcb.2013.06.005
   PubMed Web of Science ®Google Scholar
• Das UN. 1999. Essential fatty acids, lipid peroxidation and apoptosis. Prostaglandins Leukot Essent Fatty Acids. 61(3):157–163. doi: 10.1054/plef.1999.0085
   PubMed Web of Science ®Google Scholar
• Hall MN, Chavarro JE, Lee I-M, Willett WC, Ma J. 2008. A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev. 17(5):1136–1143. doi: 10.1158/1055-9965.EPI-07-2803
   PubMed Web of Science ®Google Scholar
• Hannah VC, Ou J, Luong A, Goldstein JL, Brown MS. 2001. Unsaturated fatty acids down-regulate SREBP isoforms 1a and 1c by two mechanisms in HEK-293 cells. J Biol Chem. 276(6):4365–4372. doi: 10.1074/jbc.M007273200
   PubMed Web of Science ®Google Scholar
• Harris WS, Dayspring TD, Moran TJ. 2013. Omega-3 fatty acids and cardiovascular disease: new developments and applications. Postgrad Med. 125(6):100–113. doi: 10.3810/pgm.2013.11.2717
   PubMed Web of Science ®Google Scholar
• Horton JD, Goldstein JL, Brown MS. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 109(9):1125–1131. doi: 10.1172/JCI0215593
   PubMed Web of Science ®Google Scholar
• Howell G, Deng X, Yellaturu C, Park EA, Wilcox HG, Raghow R, Elam MB. 2009. N-3 polyunsaturated fatty acids suppress insulin-induced SREBP-1c transcription via reduced trans-activating capacity of LXRα. Biochim Biophys Acta. 1791(12):1190–1196. doi: 10.1016/j.bbalip.2009.08.008
   PubMed Web of Science ®Google Scholar
• Kawamori T, Rao CV, Seibert K, Reddy BS. 1998. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 58(3):409–412.
   PubMed Web of Science ®Google Scholar
• Kim H, Rodriguez-Navas C, Kollipara Rahul K, Kapur P, Pedrosa I, Brugarolas J, Kittler R, Ye J. 2015. Unsaturated fatty acids stimulate tumor growth through stabilization of β-catenin. Cell Rep. 13(3):495–503. doi: 10.1016/j.celrep.2015.09.010
   PubMed Web of Science ®Google Scholar
• Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. 2004. Dietary long-chain n−3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr. 79(6):935–945. doi: 10.1093/ajcn/79.6.935
   PubMed Web of Science ®Google Scholar
• Moon Y-A, Hammer RE, Horton JD. 2009. Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice. J Lipid Res. 50(3):412–423. doi: 10.1194/jlr.M800383-JLR200
   PubMed Web of Science ®Google Scholar
• Moon Y-A, Shah NA, Mohapatra S, Warrington JA, Horton JD. 2001. Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins. J Biol Chem. 276(48):45358–45366. doi: 10.1074/jbc.M108413200
   PubMed Web of Science ®Google Scholar
• Morland SL, Martins KJB, Mazurak VC. 2016. N-3 polyunsaturated fatty acid supplementation during cancer chemotherapy. J Nutr Intermed Metab. 5:107–116. doi: 10.1016/j.jnim.2016.05.001
   Google Scholar
• Morton JD, Shimomura I. 1999. Sterol regulatory element-binding proteins. Curr Opin Lipidol. 10:143–150. doi: 10.1097/00041433-199904000-00008
   PubMed Web of Science ®Google Scholar
• Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM. 1996. Suppression of intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 87(5):803–809. doi: 10.1016/S0092-8674(00)81988-1
   PubMed Web of Science ®Google Scholar
• Patterson E, Wall R, Fitzgerald GF, Ross RP, Stanton C. 2012. Health implications of high dietary omega-6 polyunsaturated fatty acids. J Nutr Metab. 2012:1–16. doi: 10.1155/2012/539426
   Google Scholar
• Rose DP, Connolly JM. 1990. Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture. Cancer Res. 50(22):7139–7144.
   PubMed Web of Science ®Google Scholar
• Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T. 1995. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55(17):3785–3789.
   PubMed Web of Science ®Google Scholar
• Sawada N, Inoue M, Iwasaki M, Sasazuki S, Shimazu T, Yamaji T, Takachi R, Tanaka Y, Mizokami M, Tsugane S. 2012. Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma. Gastroenterology. 142(7):1468–1475. doi: 10.1053/j.gastro.2012.02.018
   PubMed Web of Science ®Google Scholar
• Shiragami R, Murata S, Kosugi C, Tezuka T, Yamazaki M, Hirano A, Yoshimura Y, Suzuki M, Shuto K, Koda K. 2013. Enhanced antitumor activity of cerulenin combined with oxaliplatin in human colon cancer cells. Int J Oncol. 43(2):431–438. doi: 10.3892/ijo.2013.1978
   PubMed Web of Science ®Google Scholar
• Simopoulos AP. 2002. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 21(6):495–505. doi: 10.1080/07315724.2002.10719248
   PubMed Web of Science ®Google Scholar
• Song M, Zhang X, Meyerhardt JA, Giovannucci EL, Ogino S, Fuchs CS, Chan AT. 2017. Marine ω-3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis. Gut. 66(10):1790–1796. doi: 10.1136/gutjnl-2016-311990
   PubMed Web of Science ®Google Scholar
• Tanaka A, Yamamoto A, Murota K, Tsujiuchi T, Iwamori M, Fukushima N. 2017. Polyunsaturated fatty acids induce ovarian cancer cell death through ROS-dependent MAP kinase activation. Biochem Biophys Res Commun. 493(1):468–473. doi: 10.1016/j.bbrc.2017.08.168
   PubMed Web of Science ®Google Scholar
• Williams CD, Whitley BM, Hoyo C, Grant DJ, Iraggi JD, Newman KA, Gerber L, Taylor LA, McKeever MG, Freedland SJ. 2011. A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer. Nutr Res. 31(1):1–8. doi: 10.1016/j.nutres.2011.01.002
   PubMed Web of Science ®Google Scholar
• Zivkovic AM, German JB, Sanyal AJ. 2007. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr. 86(2):285–300. doi: 10.1093/ajcn/86.2.285
   PubMed Web of Science ®Google Scholar